Logo Image
News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer ExchangeShorts
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Asembia AXS26 Summit|
Digital Editions|
Security
Advertisement
|Articles|August 20, 2019

Prospectus For Establishment of a DSCSA Governance Body

Advertisement

Click on the link below to read the document:

Final Governance Prospectus Document_080919

Advertisement
Legal & Regulatory

Related Content

Advertisement

How GLP-1 Growth and Specialty Drugs Are Driving Cost Pressure

ByPhilip Sclafani,Stephen Appezzato
June 18th 2026
As payers and employers finalize 2027 benefit designs, oncology, GLP-1s and PBM economics aren't just structural cost drivers — they're also where formulary placement, contracting terms and channel design decisions get made. | © Shutterly - stock.adobe.com (1895980492)

Report: GLP-1s, Oncology to Drive Drug Spending Surge in 2027

ByStephen Appezzato
June 18th 2026
Pharma Pulse

Pharma Pulse: Drug Pricing Pressure in Europe and the New DSV Air Route

ByStephen Appezzato
June 17th 2026

Why Packaging Is Now a Frontline Issue In Pharma Supply Chains

ByAlex Guillen
June 17th 2026
Mobile phone with logo of Centers for Medicare and Medicaid Services (CMS) on screen in front of website. Focus on center-left of phone display. | © Timon - stock.adobe.com (533699257)

CMS Could Make Drug Price Negotiations Permanent - What it Means for Pharma

ByStephen Appezzato
June 16th 2026
Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

CMS Could Make Drug Price Negotiations Permanent - What it Means for Pharma

2

Report: GLP-1s, Oncology to Drive Drug Spending Surge in 2027

3

Why Packaging Is Now a Frontline Issue In Pharma Supply Chains

4

Pharma Pulse: Drug Pricing Pressure in Europe and the New DSV Air Route

5

FAQ: Strait of Hormuz Reopening — What It Means for Pharma Supply Chains

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us